Identification of a new complex deleterious mutation in exon 18 of the BRCA2 gene in a hereditary male/female breast cancer family (original) (raw)
A new mutation of BRCA2 gene in an Italian healthy woman with familial breast cancer history
Maria Maddalena Galante
Familial Cancer, 2010
View PDFchevron_right
A novel de novo BRCA1 mutation in a Chinese woman with early onset breast cancer
Ava Kwong
Familial Cancer, 2011
View PDFchevron_right
Spectrum and frequencies of BRCA1/2 mutations in Bulgarian high risk breast cancer patients
Rumyana Dodova
BMC Cancer, 2015
View PDFchevron_right
BRCA1 and BRCA2 mutations in breast/ovarian cancer patients from central Italy
Patrizia Di Fulvio
Human Mutation, 2003
View PDFchevron_right
Clinicopathological characteristics and BRCA1/BRCA2 pathogenic variants of patients with breast cancer
Zuhal Altıntaş
Polish Journal of Pathology, 2024
View PDFchevron_right
Italian family with two independent mutations: 3358T/A in BRCA1 and 8756delA in BRCA2 genes
Daniela Turchetti
European Journal of Human Genetics, 2003
View PDFchevron_right
Germ line BRCA1 & BRCA2 mutations in Greek breast/ovarian cancer families: 5382insC is the most frequent mutation observed
Christina Tsionou
Cancer Letters, 2002
View PDFchevron_right
BRCA1 and TP53 Gene-Mutations: Family Predisposition and Radioecological Risk of Developing Breast Cancer
lina Guevara
2016
View PDFchevron_right
High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area
L. Petruzelka
Breast Cancer Research, 2005
View PDFchevron_right
Identification of a BRCA2-Specific Modifier Locus at 6p24 Related to Breast Cancer Risk
G. Rennert
PLoS Genetics, 2013
View PDFchevron_right
BARD1 homozygous deletion, a possible alternative to BRCA1 mutation in basal breast cancer
Max Chaffanet
Genes, Chromosomes and Cancer, 2010
View PDFchevron_right
Analysis of BRCA1 and BRCA2 mutations in Brazilian breast cancer patients with positive family history
Rozany Dufloth
Sao Paulo Medical Journal, 2005
View PDFchevron_right
Greek BRCA1 and BRCA2 mutation spectrum: two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patients
Theodore Anagnostopoulos
Breast Cancer Research and Treatment, 2007
View PDFchevron_right
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers
diana torres
Journal of the National Cancer Institute, 2016
View PDFchevron_right
Case report of a rare variant of BRCA2 germline mutation in an ovarian cancer patient
Vaishnavi Kunteepuram
Indian Journal of Gynecologic Oncology, 2020
View PDFchevron_right
BRCA1 mutations and clinicopathological features in a sample of Italian women with early-onset breast cancer
Daniela Turchetti
European Journal of Cancer, 2000
View PDFchevron_right
Common genetic variation at BARD1 is not associated with Breast cancer risk in BRCA1 or BRCA2 mutation carriers
Susan Neuhausen
… Biomarkers & Prevention, 2011
View PDFchevron_right
Founder BRCA1 mutations and two novel germline BRCA2 mutations in breast and/or ovarian cancer families from North-Eastern Poland
Janusz Limon
Human Mutation, 2000
View PDFchevron_right
Mutation analysis of the BRCA1 and BRCA2 genes results in the identification of novel and recurrent mutations in 6/16 Flemish families with breast and/or ovarian cancer but not in 12 sporadic patients with early-onset disease
Ludwine Messiaen
Human Mutation, 1999
View PDFchevron_right
A founder BRCA2 mutation in non-Afrikaner breast cancer patients of the Western Cape of South Africa
Nerina van der Merwe
Clinical Genetics, 2011
View PDFchevron_right
Population-based study of BRCA1/2 mutations: Family history based criteria identify minority of mutation carriers
L. Petruzelka
Neoplasma, 2010
View PDFchevron_right
A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population
GUSTAVO RODRIGUEZ
2010
View PDFchevron_right
Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility
Jan Kleibeuker
Journal of Medical Genetics, 2002
View PDFchevron_right
Identification of BRCA1/2 Founder Mutations in Southern Chinese Breast Cancer Patients Using Gene Sequencing and High Resolution DNA Melting Analysis
Ava Kwong
PLoS ONE, 2012
View PDFchevron_right
Genetic Analysis of BRCA1 Function in a Defined Tumor Cell Line
Merav Socolovsky
Molecular Cell, 1999
View PDFchevron_right
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
J. Gronwald
The American Journal of Human Genetics, 2003
View PDFchevron_right
Pathologic Features and Immunophenotype of Estrogen Receptor–positive Breast Cancers in BRCA1 Mutation Carriers
Katharina Fetten
American Journal of Surgical Pathology, 2012
View PDFchevron_right
Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)
Mary Beattie
Cancer Epidemiology Biomarkers & Prevention, 2012
View PDFchevron_right
An entire exon 3 germ-line rearrangement in the BRCA2 gene: pathogenic relevance of exon 3 deletion in breast cancer predisposition
Rosette Lidereau
BMC Medical Genetics, 2011
View PDFchevron_right
Potential Excess Mortality in BRCA1/2 Mutation Carriers beyond Breast, Ovarian, Prostate, and Pancreatic Cancers, and Melanoma
Patricia Hartge
PLoS ONE, 2009
View PDFchevron_right
Frequency of three BRCA1 gene founder mutations in breast/ovarian cancer families from the Pomerania-Kujawy region of Poland
Magdalena Pasinska
Clinical Genetics, 2003
View PDFchevron_right
Description and analysis of genetic variants in French hereditary breast and ovarian cancer families recorded in the UMD-BRCA1/BRCA2 databases
Sandrine M Caputo
Nucleic Acids Research, 2011
View PDFchevron_right
Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers
Edu Velasco
Breast cancer research …, 2010
View PDFchevron_right
Complete allelic analysis of BRCA1 and BRCA2 variants in young Nigerian breast cancer patients
rasaaq Oyesegun
Journal of Medical Genetics, 2005
View PDFchevron_right
DHPLC/SURVEYOR Nuclease: A Sensitive, Rapid and Affordable Method to Analyze BRCA1 and BRCA2 Mutations in Breast Cancer Families
Simona De Summa
Molecular Biotechnology, 2012
View PDFchevron_right